Skip to content

ROX Index in Acute Respiratory Failure

Role of ROX Index as an Indicator for Non-invasive Ventilation in Acute Respiratory Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05309239
Enrollment
100
Registered
2022-04-04
Start date
2022-03-21
Completion date
2024-03-01
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rox Index

Brief summary

evaluation of ROX index among ICU patients to evaluate the success of non invasive ventilation or the need for intubation

Interventions

observation of ROX index to evaluate the efficacy of non invasive ventilation

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Participants admitted to RICU with type I and type II respiratory failure requiring NIV support with one or more of the following : 1. PaO2/FiO2 less than or equal to 300 mmHg despite supplying oxygen at a flow rate ≥ to 10 l/min for ≥ 15 min 2. Patients requiring ventilatory support due to increased respiratory rate ≥ 25 breaths/min or using accessory muscles of respiration

Exclusion criteria

* 1\. Absolute indication for intubation like coma, hemodynamic instability, or life-threatening arrhythmia. 2\. Contraindication to NIV like untreated pneumothorax, pneumothorax with air leak, widespread facial burn or trauma, tracheotomy,or active upper gastrointestinal bleeding. 3\. Resusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Success vs failure of non invasive ventilationwithin 6 monthsby ROX index calculation

Countries

Egypt

Contacts

Primary ContactKholoud zakaria mahmoud, Master
kholoudzakaria9@gmail.com01024529525

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026